Consider TLR5 for new therapeutic development against COVID‐19
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang‐Soo Lee, Govindasamy Agoramoorthy
Topics & Concepts
VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus InfectionsTLR5MedicineBiologyImmunologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseToll-like receptorInnate immune systemImmune systemCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmune Response and Inflammation